United States Pharmaceutical Supply Chain Management Market Forecast 2023-2030

The United States pharmaceutical supply chain management market is predicted to grow with a CAGR of 8.84% over the forecast years of 2023-2030. The market growth of the country is fuelled by the high rates of digital transformation, the surging adoption of innovative and cutting-edge technologies, and increasing expenditure on pharmaceuticals.

MARKET INSIGHTS

Larger United States healthcare providers are inclined towards purchasing or leasing their distribution centers and operating their truck fleets. The decision to ensure that distribution is in-house is mainly on account of establishing direct control over issues like legal compliance, specifically for pharmaceutical supply. In addition, several organizations assert that in-sourcing hospital supply chains lead to significant cost savings, as well. For instance, Mercy Health System, a United States healthcare provider, resolved to insource storage and transportation, thus saving upto 30% annually on distribution costs and logistics.

Conversely, the Drug Supply Chain Security Act (DSCSA), Title II of the DQSA, elaborates procedures to accomplish interoperable, electronic tracking of goods at the package level in order to identify and trace specific prescription medications as they are distributed across the United States. This step will likely enhance the Food and Drug Administration's (FDA) capacity, thus safeguarding customers from stolen, counterfeit, tainted, or otherwise hazardous pharmaceuticals. Furthermore, these measures will also help enhance the identification and subsequent removal of potentially harmful medicines from the drug supply chain. Hence, the aforementioned factors are set to propel the United States pharmaceutical supply chain management market growth during the estimated period.

COMPETITIVE INSIGHTS

Leading players in the market are: Oracle Corporation, Cardinal Health, McKesson Corporation, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 51596

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. INCREASING APPLICATION OF CLOUD COMPUTING SYSTEMS IN HEALTHCARE
- 3.1.2. ADOPTION OF GS1 STANDARD SYSTEM
- 3.1.3. GROWING PRESSURE TO REDUCE HEALTHCARE COSTS
- 3.1.4. SURGING DEMAND FOR PHARMACEUTICALS PRODUCTS
- 3.1.5. HIGH PREVALENCE OF DRUG COUNTERFEITING IN THE PHARMA INDUSTRY
3.2. KEY RESTRAINTS
- 3.2.1. STRINGENT REGULATIONS IN HEALTHCARE DATA EXCHANGE
- 3.2.2. HIGH OPERATIONAL COSTS OF HEALTHCARE SCM SOFTWARE
- 3.2.3. TECHNICAL PROBLEMS ASSOCIATED WITH SCM SOFTWARE
- 3.2.4. SECURITY ISSUES IN WEAK SCM LINKS

4. KEY ANALYTICS

4.1. KEY TECHNOLOGY TRENDS
4.2. PORTER'S FIVE FORCES
- 4.2.1. BUYERS POWER
- 4.2.2. SUPPLIERS POWER
- 4.2.3. SUBSTITUTION
- 4.2.4. NEW ENTRANTS
- 4.2.5. INDUSTRY RIVALRY
4.3. MARKET CONCENTRATION ANALYSIS

5. MARKET BY COMPONENT

5.1. SOLUTION
- 5.1.1. TRANSPORTATION MANAGEMENT SYSTEM
- 5.1.2. PLANNING & ANALYTICS
- 5.1.3. WAREHOUSE & INVENTORY MANAGEMENT SYSTEM
- 5.1.4. PROCUREMENT & SOURCING
- 5.1.5. MANUFACTURING EXECUTION SYSTEM
5.2. SERVICE
- 5.2.1. PROFESSIONAL SERVICES
- 5.2.2. MANAGED SERVICES

6. MARKET BY DEPLOYMENT MODE

6.1. ON-PREMISE
6.2. CLOUD-BASED

7. COMPETITIVE LANDSCAPE

7.1. KEY STRATEGIC DEVELOPMENTS
- 7.1.1. PRODUCT LAUNCHES
- 7.1.2. PARTNERSHIPS
7.2. COMPANY PROFILES
- 7.2.1. CARDINAL HEALTH
  - 7.2.1.1. COMPANY OVERVIEW
  - 7.2.1.2. PRODUCTS / SERVICES LIST
  - 7.2.1.3. STRENGTHS & CHALLENGES
- 7.2.2. INFOR
  - 7.2.2.1. COMPANY OVERVIEW
  - 7.2.2.2. PRODUCTS / SERVICES LIST
  - 7.2.2.3. STRENGTHS & CHALLENGES
- 7.2.3. MANHATTAN ASSOCIATES
  - 7.2.3.1. COMPANY OVERVIEW
  - 7.2.3.2. PRODUCTS / SERVICES LIST
  - 7.2.3.3. STRENGTHS & CHALLENGES
- 7.2.4. MCKESSON CORPORATION
  - 7.2.4.1. COMPANY OVERVIEW
  - 7.2.4.2. PRODUCTS / SERVICES LIST
  - 7.2.4.3. STRENGTHS & CHALLENGES
- 7.2.5. ORACLE CORPORATION
  - 7.2.5.1. COMPANY OVERVIEW
  - 7.2.5.2. PRODUCTS / SERVICES LIST
  - 7.2.5.3. STRENGTHS & CHALLENGES
- 7.2.6. SAP SE
  - 7.2.6.1. COMPANY OVERVIEW
  - 7.2.6.2. PRODUCTS / SERVICES LIST
  - 7.2.6.3. STRENGTHS & CHALLENGES
- 7.2.7. TECSYS INC
  - 7.2.7.1. COMPANY OVERVIEW
  - 7.2.7.2. PRODUCTS / SERVICES LIST
  - 7.2.7.3. STRENGTHS & CHALLENGES

Product Code: 51596

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT
TABLE 2: PRIMARY FACTORS CONTRIBUTING TO THE WIDESPREAD PRESENCE OF COUNTERFEIT GOODS
TABLE 3: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COMPONENT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 4: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COMPONENT, FORECAST YEARS, 2023-2030 (IN $ MILLION)
TABLE 5: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 6: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, FORECAST YEARS, 2023-2030 (IN $ MILLION)
TABLE 7: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 8: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, FORECAST YEARS, 2023-2030 (IN $ MILLION)
TABLE 9: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 10: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODE, FORECAST YEARS, 2023-2030 (IN $ MILLION)
TABLE 11: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET REGULATORY FRAMEWORK
TABLE 12: LIST OF PRODUCT LAUNCHES
TABLE 13: LIST OF PARTNERSHIPS

LIST OF FIGURES

FIGURE 1: KEY TECHNOLOGY TRENDS
FIGURE 2: PORTER'S FIVE FORCES
FIGURE 3: MARKET CONCENTRATION ANALYSIS
FIGURE 4: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, GROWTH POTENTIAL, BY COMPONENT, IN 2022
FIGURE 5: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, 2023-2030 (IN $ MILLION)
FIGURE 6: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, GROWTH POTENTIAL, BY SOLUTION, IN 2022
FIGURE 7: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY TRANSPORTATION MANAGEMENT SYSTEM, 2023-2030 (IN $ MILLION)
FIGURE 8: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PLANNING & ANALYTICS, 2023-2030 (IN $ MILLION)
FIGURE 9: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY WAREHOUSE & INVENTORY MANAGEMENT SYSTEM, 2023-2030 (IN $ MILLION)
FIGURE 10: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PROCUREMENT & SOURCING, 2023-2030 (IN $ MILLION)
FIGURE 11: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY MANUFACTURING EXECUTION SYSTEM, 2023-2030 (IN $ MILLION)
FIGURE 12: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, 2023-2030 (IN $ MILLION)
FIGURE 13: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, GROWTH POTENTIAL, BY SERVICE, IN 2022
FIGURE 14: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PROFESSIONAL SERVICES, 2023-2030 (IN $ MILLION)
FIGURE 15: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY MANAGED SERVICES, 2023-2030 (IN $ MILLION)
FIGURE 16: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, GROWTH POTENTIAL, BY DEPLOYMENT MODE, IN 2022
FIGURE 17: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY ON-PREMISE, 2023-2030 (IN $ MILLION)
FIGURE 18: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY CLOUD-BASED, 2023-2030 (IN $ MILLION)